Animal Health Market Size is valued at USD 62.3 Bn in 2024 and is predicted to reach USD 128.7 Bn by the year 2034 at an 7.5% CAGR during the forecast period for 2025-2034.
Animal health encompasses the overall well-being and medical treatment of animals, including companion animals, exotic species, wildlife, aquatic creatures, and livestock. It covers various aspects such as biosecurity, nutrition, welfare, disease prevention, and treatment. The rising number of zoonotic infection outbreaks is driving significant investments in antimicrobial treatments, diagnostics, and vaccinations to control disease spread. Governments are implementing stricter regulations and surveillance initiatives to monitor and prevent zoonotic diseases, while public awareness campaigns promote responsible pet ownership and vaccination to reduce community health risks. The livestock industry is adopting biosecurity measures to prevent outbreaks and ensure compliance with food safety standards.
Moreover, the animal health industry is shifting toward preventive care for both companion animals and livestock, driven by growing awareness of early disease detection and proactive management. Animal health is critical for farmers to prevent financial losses, minimize environmental impact, and protect public health by addressing zoonotic diseases and food safety concerns. Innovations in veterinary healthcare have successfully contained diseases like avian flu and are paving the way for eradicating other illnesses. Animals also play a crucial role in human life by providing companionship, food, and protection and contributing to biological research. The growing global pet population, including 113 million cats and 92 million dogs in the EU, 67 million cats and 74 million dogs in China, and 65 million cats and 85 million dogs in the USA, has driven increased demand for veterinary services, medications, advanced treatments, and preventive care, further boosting the animal health industry.
• Virbac S.A.
• NEOGEN Corporation
• Zoetis Inc.
• Vetoquinol S.A.
• Dechra Pharmaceuticals plc
• Mars Inc.
• Animalcare Group plc
• Bimeda
• Biognesis Bag
• Bioveta
• China Animal Husbandry Industry Company
• Chanelle
• ImmuCell Corporation
• Laboratorios CALIER, S.A
• HIPRA, S.A.
• Norbrook Laboratories
• Alembic Animal Health
• Boehringer Ingelheim GmbH
• Elanco
• IDEXX Laboratories, Inc.
• Ceva Santé Animale
• Merck & Co Inc.
• Other Prominent Players
The Animal Health Market is segmented based on the by-product, pharmaceuticals, and, animal, distribution channel, end user. Based on the product, the market is divided into pharmaceuticals, biologics, medicinal feed additives, diagnostics, equipment & disposables, and others. Based on the Animal, the market is divided into companion animals and production animals. Based on the distribution channel, the market is divided into hospital/ clinic pharmacy, retail, and e-commerce. Based on the end user, the market is divided into veterinary hospitals & clinics, veterinary reference laboratories, home use, others.The Diagnostics Segment is Expected to Have the Highest Growth Rate During the Forecast Period
The diagnostics are divided into consumables and instruments. Early diagnosis enables timely intervention, reducing disease spread and mortality, while the growing pet ownership and humanization of pets are driving demand for preventive health check-ups. Wellness diagnostics for allergies, metabolic disorders, and genetic diseases are becoming increasingly popular as pet owners prioritize proactive healthcare. Technological advancements such as next-generation sequencing (NGS) and AI-powered diagnostics enhance early disease identification, improving treatment outcomes. Additionally, IoT-based wearable devices allow real-time monitoring of animal health, ensuring continuous tracking and early detection of potential health issues.
Based on the end user, the market is divided into veterinary hospitals & clinics, veterinary reference laboratories, home use, and others. Among these, the veterinary hospitals & clinics segment dominates the market. The segment's expansion was aided by the rise in pet clinics and hospitals as well as public awareness of the spread of zoonotic illnesses. Because more people are becoming aware of the importance of taking preventative care of their pets and their well-being, the diagnostic centers segment is expected to expand quickly for the forecast period. Additionally, the market is being driven by the development of molecular diagnostic procedures like PCR and ELISA, which now make up a significant portion of the animal healthcare center.
North America having large-scale animal mortality due to zoonotic and livestock diseases is the main causes of the dominant share. Furthermore, the substantial share can be attributed to many variables, including the existence of major market competitors, sophisticated healthcare infrastructure, and high healthcare spending. Additionally, it is thought that the existence of healthcare services and activities to support animal health expands this region's potential for growth. For example, to solve the issues impacting the animal health sector, the North American Pet Health Insurance Association is raising awareness of pet health insurance coverage and creating and investigating collaborations. Effective actions performed by animal welfare groups in the case of an emergency or sudden outbreak of disease are also believed to be important factors contributing to the expansion of this region.
• In Jan 2025, Ceva Animal Health declared that it has acquired the rights to use Touchlight's dbDNA technology in the animal health industry to develop and market products in the future. Ceva and Torchlight hope to work together to develop a program to manufacture novel DNA vaccines for animal health under the direction of Dr. Ian Thompson, a world authority on vaccinations.
• In Nov 2024, MSD Animal Health, which is a part of Merck & Co., announced that BRAVECTO® TriUNO, a novel chewable tablet for dogs, has received approval from the European Commission. Targeting both internal and external parasites, this medicine is a formulation of BRAVECTO (fluralaner).
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 59.0 Bn |
|
Revenue Forecast In 2034 |
USD 128.7 Bn |
|
Growth Rate CAGR |
CAGR of 7.5% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Pharmaceuticals, And, Animal, Distribution Channel, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; Japan; South Korea; Southeast Asia |
|
Competitive Landscape |
Virbac S.A., NEOGEN Corporation, Zoetis Inc., Vetoquinol S.A., Dechra Pharmaceuticals plc, Mars Inc., Animalcare Group plc, Bimeda, Biognesis Bag, Bioveta, China Animal Husbandry Industry Company, Chanelle, ImmuCell Corporation, Laboratorios CALIER, S.A, HIPRA, S.A., Norbrook Laboratories, Alembic Animal Health, Boehringer Ingelheim GmbH, Elanco, IDEXX Laboratories, Inc., Ceva Santé Animale, Merck & Co Inc. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Novel Feed Additives Market Snapshot
Chapter 4. Global Novel Feed Additives Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Novel Feed Additives Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Novel Feed Additives Industry Trends
Chapter 5. Novel Feed Additives Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share By Products, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Ingredients:
5.2.1. Pharmaceuticals
5.2.1.1. Parasiticides
5.2.1.2. Anti-infectives
5.2.1.3. Anti-inflammatory
5.2.1.4. Analgesic
5.2.1.5. Others
5.2.2. Biologics
5.2.2.1. Vaccines
5.2.2.1.1. Modified/ Attenuated Live
5.2.2.1.2. Inactivated (Killed)
5.2.2.1.3. Others
5.2.2.2. Other Biologics
5.2.3. Medicinal Feed Additives
5.2.4. Diagnostics
5.2.4.1. Consumables
5.2.4.2. Instruments
5.2.5. Equipment & Disposables
5.2.5.1. Critical Care Consumables
5.2.5.2. Anesthesia Equipment
5.2.5.3. Fluid Management Equipment
5.2.5.4. Temperature Management Equipment
5.2.5.5. Rescue & Resuscitation Equipment
5.2.5.6. Research Equipment
5.2.5.7. Patient Monitoring Equipment
5.2.6. Others
5.2.6.1. Veterinary Software
5.2.6.2. Veterinary Telehealth
5.2.6.3. Livestock Monitoring
Chapter 6. Novel Feed Additives Market Segmentation 2: By Animal Type, Estimates & Trend Analysis
6.1. Market Share By Animal Type, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sourcess:
6.2.1. Companion animals
6.2.1.1. Dogs
6.2.1.2. Cats
6.2.1.3. Horses
6.2.1.4. Other
6.2.2. Production Animals
6.2.2.1. Cattle
6.2.2.2. Swine
6.2.2.3. Poultry
6.2.2.4. Sheep & Goats
6.2.2.5. Fish
Chapter 7. Novel Feed Additives Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share By Distribution Channel, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Forms:
7.2.1. Hospital/ Clinic Pharmacy
7.2.2. Retail
7.2.3. E-commerce
Chapter 8. Novel Feed Additives Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share By End User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Speciess:
8.2.1. Veterinary Hospitals & Clinics
8.2.2. Veterinary Reference Laboratories
8.2.3. Home Use
8.2.4. Others
Chapter 9. Novel Feed Additives Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Novel Feed Additives Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Products, 2021-2034
9.2.3. North America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
9.2.4. North America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
9.2.5. North America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.3. Europe
9.3.1. Europe Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Products, 2021-2034
9.3.3. Europe Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
9.3.4. Europe Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
9.3.5. Europe Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Products, 2021-2034
9.4.3. Asia Pacific Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
9.4.4. Asia Pacific Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
9.4.5. Asia Pacific Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Products, 2021-2034
9.5.3. Latin America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
9.5.4. Latin America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
9.5.5. Latin America Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Products, 2021-2034
9.6.3. Middle East & Africa Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
9.6.4. Middle East & Africa Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
9.6.5. Middle East & Africa Novel Feed Additives Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Virbac S.A.
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerIngredientsance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. NEOGEN Corporation
10.2.3. Zoetis Inc.
10.2.4. Vetoquinol S.A.
10.2.5. Dechra Pharmaceuticals plc
10.2.6. Mars Inc.
10.2.7. Animalcare Group plc
10.2.8. Bimeda
10.2.9. Biognesis Bag
10.2.10. Bioveta
10.2.11. China Animal Husbandry Industry Company
10.2.12. Chanelle
10.2.13. ImmuCell Corporation
10.2.14. Laboratorios CALIER, S.A
10.2.15. HIPRA, S.A.
10.2.16. Norbrook Laboratories
10.2.17. Alembic Animal Health
10.2.18. Boehringer Ingelheim GmbH
10.2.19. Elanco
10.2.20. IDEXX Laboratories, Inc.
10.2.21. Ceva Santé Animale
10.2.22. Merck & Co Inc.
10.2.23. Other Prominent Players
Global Animal Health Market—By Product
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesic
o Others
• Biologics
o Vaccines
? Modified/ Attenuated Live
? Inactivated (Killed)
? Others
o Other Biologics
• Medicinal Feed Additives
• Diagnostics
o Consumables
o Instruments
• Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
• Others
o Veterinary Software
o Veterinary Telehealth
o Livestock Monitoring
Global Animal Health Market – By Animal
• Companion Animals
o Dogs
o Cats
o Horses
o Others
• Production Animals
o Cattle
o Swine
o Poultry
o Sheep & Goats
o Fish
Global Animal Health Market – By Distribution Channel
• Hospital/ Clinic Pharmacy
• Retail
• E-commerce
Global Animal Health Market – By End User
• Veterinary Hospitals & Clinics
• Veterinary Reference Laboratories
• Home Use
• Others
Global Animal Health Market – By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
